These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35654833)

  • 1. Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis.
    Moschino L; Ramaswamy VV; Reiss IKM; Baraldi E; Roehr CC; Simons SHP
    Pediatr Res; 2023 Feb; 93(3):471-491. PubMed ID: 35654833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premedication practices for less invasive surfactant administration - results from a nationwide cohort study.
    Krajewski P; Szpecht D; Hożejowski R
    J Matern Fetal Neonatal Med; 2022 Dec; 35(24):4750-4754. PubMed ID: 33356691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
    Mishra A; Joshi A; Londhe A; Deshmukh L
    Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
    Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
    Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant therapy in late preterm and term neonates with respiratory distress syndrome: a systematic review and meta-analysis.
    Ramaswamy VV; Abiramalatha T; Bandyopadhyay T; Boyle E; Roehr CC
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):393-397. PubMed ID: 34686533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
    Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
    J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premedication with Fentanyl for Less Invasive Surfactant Application (LISA): A Randomized Controlled Trial.
    Sk H; Saha B; Mukherjee S; Hazra A
    J Trop Pediatr; 2022 Feb; 68(2):. PubMed ID: 35201358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgosedation before Less-Invasive Surfactant Administration: A Systematic Review.
    Tribolet S; Hennuy N; Snyers D; Lefèbvre C; Rigo V
    Neonatology; 2022; 119(2):137-150. PubMed ID: 35124678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less Invasive Surfactant Administration (LISA) Versus INSURE Method in Preterm Infants: a Retrospective Study.
    Dini G; Santini MG; Celi F
    Med Arch; 2024; 78(2):112-116. PubMed ID: 38566872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews.
    Bruschettini M; Hassan KO; Romantsik O; Banzi R; Calevo MG; Moresco L
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013563. PubMed ID: 35199848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less invasive surfactant administration: best practices and unanswered questions.
    Herting E; Härtel C; Göpel W
    Curr Opin Pediatr; 2020 Apr; 32(2):228-234. PubMed ID: 32068592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
    Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
    Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of less invasive surfactant administration with a 5F infant feeding tube in a tertiary center of low- and middle-income countries.
    Sk MH; Saha B
    Pediatr Int; 2023; 65(1):e15668. PubMed ID: 38009628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.